Protara Therapeutics, Inc. (TARA) Tops Q2 EPS by 5c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q2 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
• Alibaba (BABA) call put ratio 2.4 calls to 1 put into quarter results
• Walmart (WMT) call put ratio 1 call to 1.7 puts into quarter results